Skyhawk Therapeutics

Skyhawk Therapeutics is a biotech company in Waltham, United States, founded in 2016. It has raised $181.0M across 3 rounds, most recently a $133.0M Series B in September 2021.

Revolutionizing disease treatment by modifying RNA expression

Employees
11–50
Founded
2016
Business Model
B2B
Total Funding
$181.0M
Last Round
$133.0M Series BSep 2021
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 2 investors for this company. The full record is or through the API.

About

Skyhawk Therapeutics is a clinical-stage biotechnology company founded in 2016 and headquartered in Waltham, Massachusetts. The company develops small molecule therapeutics that modify RNA expression via its proprietary SkySTAR platform, targeting diseases including multiple sclerosis, spinal muscular atrophy, ALS, Huntington's disease, and cancers. Skyhawk's founders co-developed Evrysdi (risdiplam), the first approved small molecule to modulate RNA splicing, for the treatment of Spinal Muscular Atrophy. The company has established pharma collaborations contributing upfront payments of over $550 million, including a strategic research collaboration with Vertex Pharmaceuticals announced in December 2020.

Summary

It lists 11–50 employees. It has raised $181.0M in total across 3 rounds, most recently a $133.0M Series B round in Sep 2021. Investors include Alexandria Venture Investments and GreatPoint Ventures.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series BSeries BSep 2021
$133.0M

Sign up to see all 3 events

Funding: Seed through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Skyhawk Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/skyhawk-therapeutics"><img src="https://indexed.vc/api/badge/company/skyhawk-therapeutics" alt="Skyhawk Therapeutics on Indexed.vc" width="260" height="76" /></a>